Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voyager Therapeutics

3.41
+0.04001.19%
Post-market: 3.410.00000.00%18:20 EDT
Volume:391.53K
Turnover:1.34M
Market Cap:188.26M
PE:-3.02
High:3.52
Open:3.32
Low:3.29
Close:3.37
Loading ...

Voyager Provides Update on Sod1 ALS Gene Therapy Program

THOMSON REUTERS
·
11 Feb

Voyager to Present at Oppenheimer 25th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
06 Feb

What Makes Voyager Therapeutics (VYGR) a New Buy Stock

Zacks
·
31 Jan

Voyager Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
27 Jan

Is it a Good Idea to Invest in Beam Therapeutics Stock Now?

Zacks
·
24 Jan

NTLA Begins Dosing in Pivotal Study on Hereditary Angioedema Candidate

Zacks
·
23 Jan

REPL Stock Rises on FDA's Priority Review for Melanoma Drug BLA

Zacks
·
23 Jan

J&J's Depression Drug Spravato Gets FDA Nod for Monotherapy Use

Zacks
·
23 Jan

Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer

Zacks
·
20 Jan

Is it a Good Idea to Invest in Stoke Therapeutics Stock Now?

Zacks
·
17 Jan

MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results

Zacks
·
17 Jan

TGTX Announces 2024 Preliminary Results, 2025 Goals, Shares Rise

Zacks
·
15 Jan

Oppenheimer Sticks to Its Buy Rating for Voyager Therapeutics (VYGR)

TIPRANKS
·
14 Jan

Cantor Fitzgerald Initiates Voyager Therapeutics at Overweight

MT Newswires Live
·
10 Jan

Should Weakness in Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Simply Wall St.
·
24 Dec 2024

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

Zacks
·
17 Dec 2024

Voyager Therapeutics Shares up 4.5% After Citigroup Starts Coverage With 'Buy'

THOMSON REUTERS
·
02 Dec 2024

BUZZ-Voyager Therapeutics rises after Citigroup starts coverage with 'buy'

Reuters
·
02 Dec 2024

Voyager Therapeutics Shares up 1.3% Premarket After Citigroup Initiates With Buy Rating

THOMSON REUTERS
·
02 Dec 2024

BUZZ-Voyager Therapeutics rises after Wedbush starts with 'outperform'

Reuters
·
29 Nov 2024